BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 35325098)

  • 21. Prognostic relevance of pleural invasion for resected NSCLC patients undergoing adjuvant treatments: A propensity score-matched analysis of SEER database.
    De Giglio A; Di Federico A; Gelsomino F; Ardizzoni A
    Lung Cancer; 2021 Nov; 161():18-25. PubMed ID: 34492552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extent of visceral pleural invasion and the prognosis of surgically resected node-negative non-small cell lung cancer.
    Seok Y; Jeong JY; Lee E
    Thorac Cancer; 2017 May; 8(3):197-202. PubMed ID: 28220643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Impact of visceral pleural invasion on the prognosis of stage Ib non-small cell lung cancer].
    Su XD; Long H; Wang X; Fu JH; He JH; Lin P; Zhang LJ; Ma GW
    Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):368-71. PubMed ID: 18953838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic impact of microscopic vessel invasion and visceral pleural invasion in non-small cell lung cancer: a retrospective analysis of 2657 patients.
    Neri S; Yoshida J; Ishii G; Matsumura Y; Aokage K; Hishida T; Nagai K
    Ann Surg; 2014 Aug; 260(2):383-8. PubMed ID: 24646539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prognostic study of visceral pleural invasion by pulmonary adenocarcinoma with tumor size ≤3 cm].
    Chen TY; Ma HW; Jin RR; Xu C; Hua HJ; Song GX; Zhang WM; Zhang ZH
    Zhonghua Bing Li Xue Za Zhi; 2017 Aug; 46(8):553-558. PubMed ID: 28810296
    [No Abstract]   [Full Text] [Related]  

  • 26. Visceral pleural invasion classification in non-small-cell lung cancer in the 7th edition of the tumor, node, metastasis classification for lung cancer: validation analysis based on a large-scale nationwide database.
    Kawase A; Yoshida J; Miyaoka E; Asamura H; Fujii Y; Nakanishi Y; Eguchi K; Mori M; Sawabata N; Okumura M; Yokoi K;
    J Thorac Oncol; 2013 May; 8(5):606-11. PubMed ID: 23478542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Visceral pleural invasion impacts the prognosis of non-small cell lung cancer: A meta-analysis.
    Liu QX; Deng XF; Zhou D; Li JM; Min JX; Dai JG
    Eur J Surg Oncol; 2016 Nov; 42(11):1707-1713. PubMed ID: 27178776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of Survival With Adjuvant Chemotherapy Among Patients With Early-Stage Non-Small Cell Lung Cancer With vs Without High-Risk Clinicopathologic Features.
    Pathak R; Goldberg SB; Canavan M; Herrin J; Hoag JR; Salazar MC; Papageorge M; Ermer T; Boffa DJ
    JAMA Oncol; 2020 Nov; 6(11):1741-1750. PubMed ID: 32940636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of visceral pleural invasion in non-small cell lung cancer: A propensity score matching study based on the SEER registry.
    Yang X; Sun F; Chen L; Shi M; Shi Y; Lin Z; Feng M; Zhan C; Jiang W; Wang Q
    J Surg Oncol; 2017 Sep; 116(3):398-406. PubMed ID: 28543219
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The association of visceral pleural invasion with skip N2 metastasis on clinical stage IA NSCLC.
    Minamoto F; Araújo P; D'Ambrosio P; Dela Vega A; Lauricella L; Pêgo-Fernandes P; Terra R
    Clinics (Sao Paulo); 2024; 79():100334. PubMed ID: 38484584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Propensity score-matched analysis of adjuvant chemotherapy for stage I non-small cell lung cancer.
    Tsutani Y; Miyata Y; Kushitani K; Takeshima Y; Yoshimura M; Okada M
    J Thorac Cardiovasc Surg; 2014 Oct; 148(4):1179-85. PubMed ID: 25112928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inclusion of multiple high-risk histopathological criteria improves the prediction of adjuvant chemotherapy efficacy in lung adenocarcinoma.
    Sereno M; He Z; Smith CR; Baena J; Das M; Hastings RK; Rake G; Fennell DA; Nakas A; Moore DA; Le Quesne J
    Histopathology; 2021 May; 78(6):838-848. PubMed ID: 33155719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic impact and initial recurrence site of lymphovascular and visceral pleural invasion in surgically resected stage I non-small-cell lung carcinoma.
    Yanagawa N; Shiono S; Abiko M; Ogata SY; Sato T; Tamura G
    Eur J Cardiothorac Surg; 2013 Sep; 44(3):e200-6. PubMed ID: 23766428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CT derived radiomic score for predicting the added benefit of adjuvant chemotherapy following surgery in stage I, II resectable non-small cell lung cancer: a retrospective multicohort study for outcome prediction.
    Vaidya P; Bera K; Gupta A; Wang X; Corredor G; Fu P; Beig N; Prasanna P; Patil PD; Velu PD; Rajiah P; Gilkeson R; Feldman MD; Choi H; Velcheti V; Madabhushi A
    Lancet Digit Health; 2020 Mar; 2(3):e116-e128. PubMed ID: 33334576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Visceral pleural invasion in T1 tumors (≤3 cm), particularly T1a, in the eighth tumor-node-metastasis classification system for non-small cell lung cancer: a population-based study.
    Zhang T; Zhang JT; Li WF; Lin JT; Liu SY; Yan HH; Yang JJ; Yang XN; Wu YL; Nie Q; Zhong WZ
    J Thorac Dis; 2019 Jul; 11(7):2754-2762. PubMed ID: 31463103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant Chemotherapy for High-risk Pathologic Stage I Non-Small Cell Lung Cancer.
    Tsutani Y; Imai K; Ito H; Miyata Y; Ikeda N; Nakayama H; Okada M
    Ann Thorac Surg; 2022 May; 113(5):1608-1616. PubMed ID: 34186090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Significance of Dual-Block Elastic Stain Evaluating Visceral Pleural Invasion in Peripheral Non-Small Cell Lung Cancer.
    Li S; Huang Y; Zhang L; Dong Z; Wu W; Zhang W; Wu C; Hou L
    Int J Surg Pathol; 2023 Apr; 31(2):175-183. PubMed ID: 35758404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjuvant Chemotherapy Improves Survival in pN-positive Clinical Stage IIIA Non-Small Cell Lung Cancer After Neoadjuvant Therapy and Resection.
    Atay SM; Amini M; Ding L; David EA; Mcfadden PM; Wightman SC; Kim AW
    Ann Thorac Surg; 2021 Jul; 112(1):197-205. PubMed ID: 33121965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjuvant chemotherapy compared with observation in patients with T2aN0 stage IB lung adenocarcinoma.
    Lee PH; Chiang CJ; Tseng JS; Zheng ZR; Chen KC; Chu CH; Huang YH; Hsu KH; Lee WC; Yang TY; Liu TW; Hsia JY; Chang GC
    Front Oncol; 2023; 13():1096683. PubMed ID: 36925928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment Modality for Stage IB Peripheral Non-Small Cell Lung Cancer With Visceral Pleural Invasion and ≤3 cm in Size.
    Huang W; Deng HY; Lin MY; Xu K; Zhang YX; Yuan C; Zhou Q
    Front Oncol; 2022; 12():830470. PubMed ID: 35280762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.